With state-of-the-art equipment and some of the field’s top experts, UCLA Health has emerged as a leader in an approach to radiation therapy that can reduce toxicity and length of treatment while ...

One of the worst diagnoses that a human can ever get in a doctor’s office is Cancer. Everyone fears cancer, and rightly so. It is a vicious disease that corrupts every speck of your being that it ...

A cancer diagnosis is hard enough; the challenges of treatment can be equally devastating. TomoTherapy, based in Madison Wisconsin, was founded with the goal of providing highly accurate radiation ...

Variation in gross tumor volume delineation using CT, MRI, and FDG-PET in planning radiotherapy of anal cancer. Background: Complete metastasectomy provides a real chance for long-term survival in ...

Accuray Inc. ARAY recently announced the receipt of 510(k) clearance for its ClearRT Helical kVCT imaging for the Radixact treatment delivery system from the FDA. This latest development is expected ...

Question: I am currently undergoing chemotherapy. If the treatments go according to schedule, I’ll be starting radiation treatment with TomoTherapy in a couple of months. Can you explain what ...

Keeping in line with its plan to expand through strategic partnerships and joint ventures, Accuray Incorporated (ARAY) entered into an exclusive three-year group purchasing agreement with a leading ...

A phase I open-label, dose-escalation study of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. Background: We evaluated the ...

Accuray has agreed to buy TomoTherapy, a creator of radiation therapy solutions for cancer care, for $4.80 per share in cash and stock, or approximately $277 million. The combined company will have an ...

SUNNYVALE, Calif., Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8 ...